Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum

• Published in: International journal of hematology Vol. 118; no. 5; pp. 609 - 617
• Main Authors: Shimura, Yuji, Shibayama, Hirohiko, Nakaya, Aya, Yamamura, Ryosuke, Imada, Kazunori, Kaneko, Hitomi, Hanamoto, Hitoshi, Fuchida, Shin-ichi, Tanaka, Hirokazu, Kosugi, Satoru, Kiyota, Miki, Matsui, Toshimitsu, Kanda, Junya, Iida, Masato, Matsuda, Mitsuhiro, Uoshima, Nobuhiko, Shibano, Masaru, Karasuno, Takahiro, Hamada, Tsuneyoshi, Ohta, Kensuke, Ito, Tomoki, Yagi, Hideo, Yoshihara, Satoshi, Shimazaki, Chihiro, Nomura, Shosaku, Hino, Masayuki, Takaori-Kondo, Akifumi, Matsumura, Itaru, Kanakura, Yuzuru, Kuroda, Junya
• Format: Journal Article
• Language: English
• Published: Singapore Springer Nature Singapore 01.11.2023; Springer Nature B.V
• Subjects: Complications; Hematology; Immunotherapy; Induction therapy; Medicine; Medicine & Public Health; Multiple myeloma; Multivariate analysis; Oncology; Original Article; Patients; Peripheral neuropathy; Targeted cancer therapy; Immunomodulatory drugs; Proteosome inhibitors; Multiple myeloma

To investigate the real-world clinical outcomes and management of novel drug-containing therapies for newly diagnosed multiple myeloma (MM) patients, we retrospectively analyzed data on the first-line treatment for newly diagnosed transplant-ineligible MM patients from Kansai Myeloma Forum, a regist...